A rigorous 2026 UK review covering the November 2025 FDA approval of Caplyta (lumateperone) for major depressive Read the full review Psychiatry & Cognitive Health 19 May 2026 Dihexa for Schizophrenia: KarXT/Cobenfy, Iclepertin CONNEX Failure, BDNF, C4 Pruning & the 2026 UK Review Can Dihexa help schizophrenia, cognitive impairment associated with schizophrenia (CIAS) or negative symptoms
Each ingredient on its own is either Category A (B) or essential with no evidence of harm at normal levels (B, B, B) or Category C in very high doses (niacin)
Instead of helping to ease symptoms, the supplements can result in further imbalances and more symptoms
According to the American Podiatric Medical Association (APMA), most people in the U.S
An injectable vitamin B12 is an effective way to prevent and correct vitamin B12 deficiency in livestock
Neurological symptoms may start improving within 12 weeks, but longstanding complications can require 36 months of treatment, with some damage potentially irreversible